Cargando…
Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study
BACKGROUND: Intravenous indomethacin has been used in infants for many years as the pharmacological closure of ductus arteriosus, but the incidence, risk, and risk factors of acute kidney injury (AKI) among infants treated with indomethacin, were still scarce. OBJECTIVES: To determine the incidence,...
Autores principales: | Raknoo, Thitinun, Janjindamai, Waricha, Sitaruno, Sirima, Dissaneevate, Supaporn, Ratanajamit, Chaveewan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013190/ https://www.ncbi.nlm.nih.gov/pubmed/35474648 http://dx.doi.org/10.18549/PharmPract.2021.4.2409 |
Ejemplares similares
-
Risk factors of transient tachypnea of the newborn developing into pulmonary hypertension of the newborn: a case-control study
por: Maneenil, Gunlawadee, et al.
Publicado: (2023) -
Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
por: Jannatdoust, Abdollah, et al.
Publicado: (2014) -
Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
por: Matsumura, Shun, et al.
Publicado: (2017) -
Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
por: Oshima, Ayumi, et al.
Publicado: (2020) -
A Case of a Full-Term Infant With Symptomatic Patent Ductus Arteriosus Successfully Closed With Indomethacin Treatment: Consideration of Mechanism for Ductus Arteriosus Closure
por: Tanabe, Junya, et al.
Publicado: (2019)